290 related articles for article (PubMed ID: 24190781)
1. Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
Brickman AM
Curr Neurol Neurosci Rep; 2013 Dec; 13(12):415. PubMed ID: 24190781
[TBL] [Abstract][Full Text] [Related]
2. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
3. Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?
Brickman AM; Muraskin J; Zimmerman ME
Dialogues Clin Neurosci; 2009; 11(2):181-90. PubMed ID: 19585953
[TBL] [Abstract][Full Text] [Related]
4. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
5. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?
Provenzano FA; Muraskin J; Tosto G; Narkhede A; Wasserman BT; Griffith EY; Guzman VA; Meier IB; Zimmerman ME; Brickman AM;
JAMA Neurol; 2013 Apr; 70(4):455-61. PubMed ID: 23420027
[TBL] [Abstract][Full Text] [Related]
7. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
[TBL] [Abstract][Full Text] [Related]
8. Cerebrovascular disease promotes tau pathology in Alzheimer's disease.
Laing KK; Simoes S; Baena-Caldas GP; Lao PJ; Kothiya M; Igwe KC; Chesebro AG; Houck AL; Pedraza L; Hernández AI; Li J; Zimmerman ME; Luchsinger JA; Barone FC; Moreno H; Brickman AM;
Brain Commun; 2020; 2(2):fcaa132. PubMed ID: 33215083
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution.
Garnier-Crussard A; Cotton F; Krolak-Salmon P; Chételat G
Alzheimers Dement; 2023 Aug; 19(8):3738-3748. PubMed ID: 37027506
[TBL] [Abstract][Full Text] [Related]
10. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
[TBL] [Abstract][Full Text] [Related]
11. An improved algorithm of white matter hyperintensity detection in elderly adults.
Ding T; Cohen AD; O'Connor EE; Karim HT; Crainiceanu A; Muschelli J; Lopez O; Klunk WE; Aizenstein HJ; Krafty R; Crainiceanu CM; Tudorascu DL
Neuroimage Clin; 2020; 25():102151. PubMed ID: 31927502
[TBL] [Abstract][Full Text] [Related]
12. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities influence distal cortical β-amyloid accumulation in default mode network pathways.
Ali DG; Bahrani AA; El Khouli RH; Gold BT; Jiang Y; Zachariou V; Wilcock DM; Jicha GA
Brain Behav; 2023 Oct; 13(10):e3209. PubMed ID: 37534614
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
[TBL] [Abstract][Full Text] [Related]
15. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
[TBL] [Abstract][Full Text] [Related]
16. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
Makedonov I; Black SE; MacIntosh BJ
Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
[TBL] [Abstract][Full Text] [Related]
17. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration.
Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC
Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
[TBL] [Abstract][Full Text] [Related]
19. White matter hyperintensities and imaging patterns of brain ageing in the general population.
Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
[TBL] [Abstract][Full Text] [Related]
20. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans.
Habes M; Pomponio R; Shou H; Doshi J; Mamourian E; Erus G; Nasrallah I; Launer LJ; Rashid T; Bilgel M; Fan Y; Toledo JB; Yaffe K; Sotiras A; Srinivasan D; Espeland M; Masters C; Maruff P; Fripp J; Völzk H; Johnson SC; Morris JC; Albert MS; Miller MI; Bryan RN; Grabe HJ; Resnick SM; Wolk DA; Davatzikos C;
Alzheimers Dement; 2021 Jan; 17(1):89-102. PubMed ID: 32920988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
